Research Topics
| David LivermoreSummaryAffiliation: Health Protection Agency Country: UK Publications
| Collaborators
|
Detail Information
Publications
In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocciAlan P Johnson
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, Colindale, London NW9 5HT, United Kingdom
Antimicrob Agents Chemother 46:321-6. 2002..015 to 0.5 microg/ml. RWJ-54428 did not select resistant mutants of MRSA or enterococci in challenge experiments and has the potential to be useful for the treatment of infections caused by gram-positive cocci...
Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanismsDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, HPA Centre for Infections, 61 Colindale Avenue, London NW9 9EQ, UK
J Antimicrob Chemother 65:2382-95. 2010..We tested BAL30376 and its components versus isolates and laboratory strains of Enterobacteriaceae and non-fermenters...
The zeitgeist of resistanceDavid Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 60:i59-61. 2007..For a resistance to 'succeed', it needs to have a mechanism that imposes little fitness burden, along with a biologically 'fit' host strain or strains. Once this combination arises, control is extremely difficult...
Can better prescribing turn the tide of resistance?David Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency, London NW9 5HT, UK
Nat Rev Microbiol 2:73-8. 2004..If resistance is unlikely to be reduced significantly by changing prescription practices, how can clinicians outpace increased resistance, particularly when much of 'big pharma' is abandoning antibiotic development?..
CTX-M: changing the face of ESBLs in EuropeDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 59:165-74. 2007..Irrespective of the particular enzyme, most producers are multiresistant. These changing patterns present major therapeutic and infection control challenges, with the public health intervention points unclear...
Temocillin revivedDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 63:243-5. 2009..In settings where these are unlikely or are covered by other agents, temocillin may be useful, potentially 'sparing' carbapenems and having little apparent potential to select for Clostridium difficile...
Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctorsDavid M Livermore
Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK
Int J Antimicrob Agents 28:273-9. 2006..Stabilisation or decline in penicillin resistance has occurred in Ireland despite stable or increasing oral beta-lactam sales...
beta-Lactamases- the Threat RenewsDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, NW9 5EQ, London, UK
Curr Protein Pept Sci 10:397-400. 2009..Tony Fink's work contributed greatly to our understanding of the mechanisms and active site function of beta-lactamases and this knowledge now informs the search for new beta-lactams and beta-lactamase inhibitors...
Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococciDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW95EQ, UK
J Antimicrob Chemother 63:713-5. 2009..TR-700 is the active moiety of TR-701 (DA-7157), a new oral/intravenous oxazolidinone prodrug. We examined its activity against linezolid-susceptible and -resistant staphylococci and enterococci...
The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and AcinetobacterDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London, NW9 5EQ, UK
Trends Microbiol 14:413-20. 2006..This review discusses the epidemiology and microbiology of these resistance problems, along with possible solutions...
The need for new antibioticsD M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency, London, UK
Clin Microbiol Infect 10:1-9. 2004..Unless antibacterial development is re-energised, there is a serious risk that a growing proportion of infections, especially in hospitals, will become effectively untreatable...
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenemsDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK
J Antimicrob Chemother 55:306-11. 2005..There is, however, concern that this use will select for resistances to imipenem and meropenem in nosocomial pathogens, notably Pseudomonas aeruginosa, and we investigated the validity of this concern...
Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolatesDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
Int J Antimicrob Agents 34:402-6. 2009..MICs of CXA-101 were 2- to 16-fold below those of ceftazidime for multiresistant P. aeruginosa from CF patients, but ranged up to > 128 mg/L; values for B. cepacia from CF resembled those for ceftazidime...
Minimising antibiotic resistanceDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London NW9 5HT, UK
Lancet Infect Dis 5:450-9. 2005..Last, there is a need to re-invigorate antimicrobial development, which has been downgraded by many major pharmaceutical houses...
Tigecycline: what is it, and where should it be used?David M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK
J Antimicrob Chemother 56:611-4. 2005..It is also likely to find a role in the treatment of infections due to multiresistant pathogens, including Acinetobacter spp. and ESBL producers, as well as MRSA and enterococci...
Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanismsDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London, NW9 5EQ, UK
J Antimicrob Chemother 64:330-5. 2009..Razupenem (previously known as PTZ601, PZ-601, SMP-601 or SM-216601) is a novel carbapenem, active against Enterobacteriaceae as well as Gram-positive bacteria including methicillin-resistant staphylococci and enterococci...
Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around LondonDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
Int J Antimicrob Agents 35:19-24. 2010..This difference was significant (P=0.003), although the patients receiving nebulised drug were mostly younger, included trauma cases and were at a hospital with good outcomes...
Has the era of untreatable infections arrived?David M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 64:i29-36. 2009..A final and surprising problem is Neisseria gonorrhoeae, where each good oral agent has been eroded in turn and where there is now little in reserve behind the oral oxyimino cephalosporins, to which low-level resistance is emerging...
Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producersD M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, Centre for Infections, London, UK
Clin Microbiol Infect 14:189-93. 2008..Combinations of clavulanate with modern anti-methicillin-resistant Staphylococcus aureus cephalosporins also deserve investigation, as these compounds remain labile to ESBLs...
In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococciDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
Antimicrob Agents Chemother 51:1112-4. 2007..RWJ-416457 MICs for mutants with 23S rRNA mutations were 2 to 32 microg/ml, versus linezolid MICs of 8 to 64 microg/ml; actual values reflected the proportion of gene copies mutated...
Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from menDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency, London, UK
J Antimicrob Chemother 52:1040-2. 2003..To assess ciprofloxacin resistance among Escherichia coli isolates from bacteraemia patients in England in relation to age, sex and Region...
Properties and potential of ertapenemDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT
J Antimicrob Chemother 52:331-44. 2003..Nevertheless, if ertapenem is to be used widely, its effects on the resistance ecology need to be monitored carefully...
Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06David M Livermore
Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 62:ii41-54. 2008..Reflecting this importance, members of the family constitute 4 of the 12 collection groups in the British Society for Antimicrobial Chemotherapy (BSAC) Bacteraemia Surveillance Programme...
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemasesDavid M Livermore
Health Protection Agency Centre for Infections, London, UK
J Antimicrob Chemother 62:1053-6. 2008..We examined whether combinations of oxyimino-cephalosporins with NXL104, a novel non-beta-lactam beta-lactamase inhibitor, overcame these resistances...
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecyclineDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Microbiology Services Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
Int J Antimicrob Agents 37:415-9. 2011..Studies with transconjugants and transformants confirmed the small effect of KPC enzymes against temocillin, whereas OXA-48 and NDM-1 conferred clear resistance...
Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06David M Livermore
Health Protection Agency Centre for Infections, 61 C olindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 62:ii55-63. 2008..Pseudomonas spp. are collected in the British Society for Antimicrobial Chemotherapy (BSAC) bacteraemia surveillance, with Acinetobacter spp. and Stenotrophomonas maltophilia well represented in the 'other Gram-negatives' group...
Strategies to overcome extended-spectrum ?-lactamases (ESBLs) and AmpC ?-lactamases in shigellaeDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Microbiology Services Colindale, 61 Colindale Avenue, London NW9 5EQ, UK
Int J Antimicrob Agents 37:405-9. 2011..Clinical utility will depend also on a drug's ability to reach intracellular shigellae in the intestinal epithelium and this deserves exploration for clavulanic acid and faropenem...
Defining an extended-spectrum beta-lactamaseD M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, London, UK
Clin Microbiol Infect 14:3-10. 2008..It seems best-and pragmatic-that the term 'ESBL' retains its broad modern usage, but that should always be accompanied by mention of the enzyme's family as, e.g., in 'TEM ESBL' or 'OXA ESBL', not as a sole moniker...
Evaluation of the chromogenic Cica-beta-Test for detecting extended-spectrum, AmpC and metallo-beta-lactamasesD M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 60:1375-9. 2007..Chromogenic tests might usefully shorten this delay, and we investigated the Cica-beta-Test for this purpose...
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolatesD M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, HPA Microbiology Services, London, UK
J Antimicrob Chemother 66:48-53. 2011..They included 53 Klebsiella spp., 19 Enterobacter spp., 6 Escherichia coli and 4 others; most were multiresistant. Genes were identified by PCR and sequencing; MICs were measured by CLSI agar dilution...
Introduction: the challenge of multiresistanceDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
Int J Antimicrob Agents 29:S1-7. 2007..One that does have increased anti-Gram-negative activity, compared with earlier analogues, is tigecycline, a glycylcycline derivative of minocycline...
Future directions with daptomycinDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, London, UK
J Antimicrob Chemother 62:iii41-iii49. 2008..There is presently a paradox whereby vancomycin is agreed to be less than ideal, with outcomes impaired against MRSA with modestly raised MICs, but where new agents have yet to demonstrate unequivocal superiority...
Antibiotic resistance: location, location, locationD M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London, UK
Clin Microbiol Infect 13:7-16. 2007....
The threat from the pink cornerDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK
Ann Med 35:226-34. 2003..Disturbingly, there is a near-total lack of developmental antibiotics active against gram-negative pathogens...
Can beta-lactams be re-engineered to beat MRSA?D M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London, UK
Clin Microbiol Infect 12:11-6. 2006..A phase II trial in skin and skin structure infection recorded cures by ceftobiprole in 4/4 MRSA infections, and results of the phase III trials are awaited with great interest...
In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British IslesD M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK
Int J Antimicrob Agents 22:14-27. 2003..Thus, if disc tests suggest that an isolate is marginally resistant to piperacillin/tazobactam and the drug is sought as therapy, it is recommended that MIC be determined with, e.g., an Etest...
Discovery research: the scientific challenge of finding new antibioticsDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, HPA Microbiology Services Colindale, 61 Colindale Avenue, London NW95EQ, UK
J Antimicrob Chemother 66:1941-4. 2011....
Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing EnterobacteriaceaeDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, HPA Centre for Infections, London, United Kingdom
Antimicrob Agents Chemother 55:390-4. 2011..with the KPC enzyme, but metallo-?-lactamase producers were resistant. Aztreonam-NXL104 was active against all carbapenemase producers at 4 and 4 ?g/ml, including those with metallo-?-lactamases...
Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United KingdomNeil Woodford
Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 62:1265-8. 2008..The aim of this study was to investigate the presence of VEB enzymes among Pseudomonas spp. referred to the UK's national reference laboratory and with phenotypic evidence of extended-spectrum beta-lactamase (ESBL) production...
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypesShazad Mushtaq
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 60:300-11. 2007..Ceftaroline (PPI-0903M, T-91825) is a novel cephalosporin, administered as an N-phosphono prodrug. We investigated its in vitro activity and resistance selection potential...
Activity of the siderophore monobactam BAL30072 against multiresistant non-fermentersShazad Mushtaq
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 65:266-70. 2010..and against laboratory P. aeruginosa strains with defined resistance mechanisms...
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patientsMaria Tomas
Centre for Infections, Health Protection Agency, London, United Kingdom
Antimicrob Agents Chemother 54:2219-24. 2010..Overexpressed mexA or ampC and reduced oprD were associated with beta-lactam resistance. A specific combination of mexR, nalC, and nalD mutations occurred in 11 Liverpool strain isolates, including 7 with upregulated mexA...
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumanniiMichael Hornsey
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 65:1589-93. 2010..baumannii clones. The role of AdeABC in the emergence of tigecycline resistance during therapy was also investigated for two representatives of the prevalent UK lineage, OXA-23 clone 1...
Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamasesShazad Mushtaq
Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency Colindale, London, NW9 5HT, United Kingdom
Antimicrob Agents Chemother 48:1313-9. 2004..5 microg/ml) of E. coli derivatives with cloned IMP-1 and NMC-A beta-lactamases suggested that carbapenem resistance might require other factors besides the enzymes...
Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007Matthew J Ellington
Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 65:446-8. 2010..2% and 35.4%, respectively). We sought to determine the proportions of these strains before and after the general decline in MRSA bacteraemia that began around 2004...
Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06Derek F J Brown
Health Protection Agency, Clinical Microbiology and Public Health Laboratory, Addenbrooke s Hospital, Cambridge CB2 2QW, UK
J Antimicrob Chemother 62:ii75-85. 2008..To describe the current patterns and trends in antimicrobial susceptibility in enterococci and streptococci (excepting pneumococci) from bacteraemia in the UK and Ireland from 2001 to 2006...
Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potentialShazad Mushtaq
Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency Colindale, London NW9 5HT, United Kingdom
Antimicrob Agents Chemother 48:3086-92. 2004..Most mutants selected with aminoglycosides and quinolones had little or no cross-resistance to carbapenems, including doripenem...
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocciAlan P Johnson
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, Colindale, London NW9 5HT, UK
J Antimicrob Chemother 50:89-93. 2002..AZD2563 was equally active against the surveillance isolates and those that had been selected for their multiresistance to other agents. The MICs of AZD2563 were either the same as those of linezolid or two-fold lower...
Two widely disseminated strains of Enterococcus faecalis highly resistant to gentamicin and ciprofloxacin from bacteraemias in the UK and IrelandNeil Woodford
Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency Colindale, London NW9 5HT UK
J Antimicrob Chemother 52:711-4. 2003..Further work is needed to characterize these two 'epidemic' E. faecalis strains and to investigate the presence of virulence genes...
The impact of carbapenemases on antimicrobial development and therapyDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Centre Public Health Laboratory, London, UK
Curr Opin Investig Drugs 3:218-24. 2002..For now, the best pharmaceutical strategy seems to lie in the development of novel antimicrobial classes with anti-Gram-negative activity, rather than in overcoming carbapenemases directly...
Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999David M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK
Emerg Infect Dis 8:473-8. 2002..1% in 1990 to 10.5% in 1996 and 10.9% in 1999. For both Klebsiella and Enterobacter spp., most resistance was localized in a few centers. Resistance was infrequent and scattered in P. mirabilis, but reached a prevalence of 3.3% in 1999...
Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)Caroline J Henwood
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK
J Antimicrob Chemother 49:479-87. 2002..In conclusion, carbapenems, colistin and minocycline retained greatest activity against the Acinetobacter isolates collected. Tigecycline was less active than minocycline, but both agents overcame most tetracycline resistance...
Detection of oxazolidinone-resistant Enterococcus faecalis and Enterococcus faecium strains by real-time PCR and PCR-restriction fragment length polymorphism analysisNeil Woodford
Antibiotic Resistance Monitoring and Reference Laboratory Laboratory of Enteric Pathogens, Central Public Health Laboratory, London NW9 5HT, United Kingdom
J Clin Microbiol 40:4298-300. 2002..Both assays detected isolates heterozygous at this position. Recognition of isolates with what is presently the most frequent oxazolidinone resistance mutation may aid surveillance and individual case management...
Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus beta-lactamase-producing EnterobacteriaceaeDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, HPA Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 65:1972-4. 2010..We investigated the tazobactam concentrations needed to potentiate this cephalosporin against strains with these mechanisms...
Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast EnglandJuliana M Coelho
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Ave, London NW9 5HT, United Kingdom
J Clin Microbiol 44:3623-7. 2006..Their spread is forcing the use of unorthodox therapies, principally colistin and tigecycline, although the optimal regimens remain uncertain...
Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistenceDavid C Bean
Centre for Infectious Disease, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
Antimicrob Agents Chemother 53:1088-93. 2009....
Bacterial resistance: origins, epidemiology, and impactDavid M Livermore
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, London NW9 5HT, United Kingdom
Clin Infect Dis 36:S11-23. 2003..Overall, the best that can reasonably be anticipated is an improved balance between the accumulation of resistance and new antibacterial development...
Activity of faropenem against cephalosporin-resistant EnterobacteriaceaeShazad Mushtaq
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, London NW9 5EQ, UK
J Antimicrob Chemother 59:1025-30. 2007..We therefore evaluated faropenem, a penem in Phase III development, against recently collected oxyimino-cephalosporin-resistant bacteria...
Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continentsJuliana Coelho
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5HT, United Kingdom
Antimicrob Agents Chemother 50:756-8. 2006..Most isolates (28 of 30) also had bla(OXA-51). We conclude that bla(OXA-58) is geographically widespread and has occurred in Acinetobacter spp. for over 10 years...
Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UKHiran Dhanji
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London, UK
J Antimicrob Chemother 65:2534-7. 2010..coli belonging to the international uropathogenic ST131 clone...
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 cloneNeil Woodford
ARMRL, Centre for Infections, Health Protection Agency, London, United Kingdom
Antimicrob Agents Chemother 53:4472-82. 2009..coli...
Infections caused by Gram-positive bacteria: a review of the global challengeNeil Woodford
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London, UK
J Infect 59:S4-16. 2009..The emergence of antibiotic resistance is inevitable, but we must seek to decrease its impact and prolong the effectiveness of the agents available to us...
Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patientsRobert L R Hill
Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 65:442-5. 2010..To describe the emergence of linezolid-resistant methicillin-resistant Staphylococcus aureus (MRSA) of sequence type (ST)36 lineage in two paediatric patients with cystic fibrosis, after long-term low-dose linezolid treatment...
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06Russell Hope
Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 62:ii65-74. 2008....
Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpiromeMichael Hornsey
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 65:479-82. 2010....
Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamasesHiran Dhanji
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London NW9 5EQ, UK
Int J Antimicrob Agents 36:355-8. 2010..coli O25b:H4 ST131 clone that commonly produces this enzyme. We describe rapid real-time polymerase chain reaction (PCR) assays able to detect E. coli belonging to the ST131 clone and to identify bla(CTX-M-15)-like...
Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatmentMichael Hornsey
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections, London NW9 5EQ, UK
Int J Antimicrob Agents 35:478-81. 2010..Treatment with ciprofloxacin, a substrate of AcrAB in E. cloacae, possibly selected for cross-resistance to tigecycline as a result of RamA-mediated AcrAB upregulation...
Tackling antibiotic resistance: a dose of common antisense?Neil Woodford
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London NW9 5EQ, UK
J Antimicrob Chemother 63:225-9. 2009....
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United KingdomNeil Woodford
Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 62:1261-4. 2008..KPC-type carbapenemases are increasingly prevalent in parts of the USA and Israel and are an emerging concern in South America, Europe and China. We investigated the UK's first two KPC-producing Klebsiella pneumoniae isolates...
Low in vitro selection frequencies of enterococcal and staphylococcal mutants resistant to the oxazolidinone AZD2563Mark W Stockdale
Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency-Colindale, 61 Colindale Ave, London NW9 5HT, UK
Int J Antimicrob Agents 23:88-91. 2004..Mutants of one E. faecalis isolate had a G2576-->U 23S rRNA mutation; mutants derived from the second E. faecalis isolate lacked this mutation...
Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003Alan P Johnson
Department of Healthcare Associated Infection and Antimicrobial Resistance, Communicable Disease Surveillance Centre, HPA Centre for Infections, Colindale, London NW9 5EQ, UK
Int J Antimicrob Agents 25:539-41. 2005..8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK...
Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agarAlan P Johnson
Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency, Specialist and Reference Microbiology Division, Colindale, London NW9 5HT, UK
J Antimicrob Chemother 53:860-2. 2004....
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter sppNeil Woodford
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Ave, London NW9 5HT, UK
Int J Antimicrob Agents 27:351-3. 2006..Genes encoding OXA-58 were detected (with bla(OXA-51-like)) in a cluster of related isolates from a single hospital. This simple assay will assist in monitoring the mechanisms responsible for carbapenem resistance in Acinetobacter spp...
Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East EnglandNicola A C Potz
Healthcare Associated Infection and Antimicrobial Resistance Department, Health Protection Agency Centre for Infections 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 58:320-6. 2006..To investigate the molecular epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in London and South-East England...
Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistanceMatthew J Ellington
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 58:848-52. 2006..Hypermutability among natural E. coli populations might facilitate the emergence of resistance to fosfomycin. We therefore examined the prevalence of mutators amongst urinary isolates of E. coli producing CTX-M beta-lactamases...
Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and IrelandNeil Woodford
Centre for Infections, Health Protection Agency, London, NW9 5EQ, UK
J Antimicrob Chemother 59:102-5. 2007..To determine the distribution of acquired AmpC beta-lactamases in 173 isolates of Escherichia coli and Klebsiella spp. submitted to the UK's national reference laboratory for antibiotic resistance...
Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002Kevin A Fenton
Communicable Disease Surveillance Centre, Health Protection Agency, London, UK
Lancet 361:1867-9. 2003..These findings suggest that national and local treatment guidelines need to be reviewed urgently...
Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratoryNeil Woodford
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, London NW9 5EQ, UK
Int J Antimicrob Agents 29:456-9. 2007..or an AmpC enzyme in Enterobacter spp. - plus impermeability and/or increased efflux. Imipenem and meropenem often remain moderately active against isolates with low-level ertapenem resistance...
Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UKHiran Dhanji
Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
J Antimicrob Chemother 66:297-303. 2011..Of these, 58 isolates belonged to UK strain A, a variant of the international ST131 clone. Here we investigated the remaining 60 ESBL producers...
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumanniiJane F Turton
Laboratory of HealthCare Associated Infection, Centre for Infections, Health Protection Agency, London, UK
FEMS Microbiol Lett 258:72-7. 2006..These results suggest that ISAba1 is providing the promoter for blaOXA-51-like and, probably, for blaOXA-23-like...
Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7)Alan Patrick Gibb
Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada T2N 4N1
Antimicrob Agents Chemother 46:255-8. 2002..They produced a novel integron-associated metallo-beta-lactamase, designated IMP-7, with 91% identity to IMP-1. bla(IMP-7) was not detected with standard bla(IMP)-specific primers, owing to mismatches in the forward primer...
False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamaseNicola A C Potz
J Antimicrob Chemother 53:545-7. 2004
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein lossDolunay Gulmez
Hacettepe University Faculty of Medicine, Department of Microbiology and Clinical Microbiology, 06100 Sihhiye, Ankara, Turkey
Int J Antimicrob Agents 31:523-6. 2008..Both isolates also had group 1 CTX-M-type ESBLs and had lost major outer membrane proteins. OXA-48-like carbapenemases appear to be scattered in Turkey and surveillance to determine their prevalence is warranted...
Detection of CTX-M-15 extended-spectrum beta-lactamase in the United KingdomShazad Mushtaq
J Antimicrob Chemother 52:528-9. 2003
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, BrazilLibera M Dalla-Costa
, Curitiba, Brazil
J Clin Microbiol 41:3403-6. 2003..Treatment options were limited, although the isolates were susceptible to polymyxin B in vitro. The strain contributed to the deaths of five patients...
Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamasesGioia S Babini
Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK
J Antimicrob Chemother 51:605-12. 2003..Elevated resistance to piperacillin + tazobactam was not associated with porin change in any ESBL producer examined, but has been found by others...
Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UKRichard P Spence
Molecular Diagnostics and Typing Unit, Public Health Laboratory, Queens Medical Centre, Nottingham NG7 2UH
J Med Microbiol 51:1107-12. 2002....
Sulfonamide resistance in Haemophilus influenzae mediated by acquisition of sul2 or a short insertion in chromosomal folPVirve I Enne
Department of Medical Microbiology, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, United Kingdom
Antimicrob Agents Chemother 46:1934-9. 2002..The two mechanisms of resistance, mediated by sul2 and modified folP, were detected in isolates from both the United Kingdom and Kenya...
bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospitalKyungwon Lee
Department of Clinical Pathology and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea
Antimicrob Agents Chemother 46:1053-8. 2002..Strict measures are required in order to control a further spread of resistance...
Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamasesSabiha Y Essack
School of Pharmacy and Pharmacology, University of Durban-Westville, Private Bag X54001, Durban 4000, South Africa
Int J Antimicrob Agents 23:398-400. 2004..The pI 8.4 activity was an AmpC-type enzyme. Determinants of the pI 5.6 and 7.6 activities were not identified...
Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin lossKyungwon Lee
Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul 120 752, South Korea
Int J Antimicrob Agents 29:201-6. 2007..pneumoniae at this Korean hospital was largely co-mediated by production of plasmid-mediated AmpC beta-lactamases along with lack or greatly diminished expression of OmpK35 and OmpK36 porins...
In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter sppNeil Woodford
J Antimicrob Chemother 59:582-3. 2007
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamaseEugenne Elliott
Department of Clinical Microbiology, Ampath Laboratories, Milpark Hospital, Johannesburg, South Africa
Clin Infect Dis 42:e95-8. 2006..All 4 isolates belonged to the same strain and produced a group 1 CTX-M enzyme; additionally, the resistant isolates had lost a porin...
Early onset Morganella morganii sepsis in a newborn infant with emergence of cephalosporin resistance caused by depression of AMPC beta-lactamase productionAjay K Sinha
Royal London Hospital, Whitechapel, UK
Pediatr Infect Dis J 25:376-7. 2006..When choosing antibiotic therapy, the risk of development of resistance to cephalosporins should be considered in infections caused by M. morganii and other Gram-negative organisms with inducible AmpC beta-lactamases...
Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007David J Farrell
Quotient Bioresearch, Microbiology, 7 9 William Road, London NW1 3ER, UK
J Antimicrob Chemother 62:ii87-95. 2008....
Susceptibility of pneumococci causing meningitis in England and Wales to first-line antimicrobial agents, 2001-2004Alan P Johnson
J Antimicrob Chemother 56:1181-2. 2005
Disagreements between disc diffusion, and MIC-based susceptibility categorizations of ertapenem versus ESBL producersJulie R Samuel
J Antimicrob Chemother 56:984-5. 2005
Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complexJoanna Empel
National Medicines Institute, ul Chełmska 30 34, 00 725 Warsaw, Poland
J Clin Microbiol 45:2829-34. 2007..It is associated with various beta-lactamases, including PER-1 and VIM metalloenzymes. This work further demonstrates the value of MLST of P. aeruginosa...
Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east EnglandDavid M Livermore
J Antimicrob Chemother 57:1012-4. 2006
Activity of ertapenem against Neisseria gonorrhoeaeDavid M Livermore
J Antimicrob Chemother 54:280-1. 2004
Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressureVirve I Enne
Bristol Centre for Antimicrobial Research, Department of Pathology and Microbiology, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD
J Antimicrob Chemother 53:958-63. 2004..To test this hypothesis, we examined the fitness impact of four naturally occurring sul2-coding plasmids upon their hosts...
